Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 4/20 | 0.55 |
| ▸ | RAB9A | P51151 | 4/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | GRM5 | P41594 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6407407 | 0.85 | EPHX1 (0.53) | NPC1RAB9AEPHX2SMN1; SMN2MEN1 | |
| SCHEMBL6403210 | 0.83 | EPHX1 (0.51) | NPC1RAB9AEPHX2SMN1; SMN2MEN1 | |
| SCHEMBL6409920 | 0.83 | ALDH1A1 (0.59) | NPC1RAB9APKMEPHX2SMN1; SMN2 | |
| SCHEMBL6407914 | 0.80 | RAB9A (0.48) | NPC1RAB9ASMN1; SMN2MEN1LMNA | |
| SCHEMBL6410506 | 0.78 | HPGD (0.46) | NPC1RAB9AEPHX2HPGDUSP2 | |
| SCHEMBL19263070 | 0.78 | ALDH1A1 (0.51) | SMN1; SMN2LMNAHTTHPGDUSP2 | |
| SCHEMBL6404110 | 0.76 | RAB9A (0.41) | NPC1RAB9ASMN1; SMN2MEN1KMT2A | |
| SCHEMBL6404107 | 0.76 | SMN1; SMN2 (0.53) | RAB9ASMN1; SMN2MEN1KMT2AALDH1A1 | |
| SCHEMBL6406598 | 0.76 | LMNA (0.61) | NPC1RAB9ASMN1; SMN2MEN1LMNA | |
| SCHEMBL6404106 | 0.76 | SMN1; SMN2 (0.53) | RAB9ASMN1; SMN2MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050171358-A1 | Substituted isoxazole alkylamine derivative and agri-and horticultural fungicide | SDS BIOTECH K.K. (JP) | 2005-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050171358-A1 | Substituted isoxazole alkylamine derivative and agri-and horticultural fungicide | AHR, ERG28, CYP1A2 | NPC1 1915/4885RAB9A 4044/4885PKM 3751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.